NCT02968511View on ClinicalTrials.gov

EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 15, 2016

Primary Completion Date

November 14, 2017

Study Completion Date

November 14, 2017

Conditions
C.Difficile Colitis
Interventions
BIOLOGICAL

fecal microbiota transplant

Fecal microbiota transplant for the treatment of severe, complicated C. difficile infection

Trial Locations (1)

17078

David Stewart, Hershey

Sponsors

Collaborators (1)

OpenBiome
All Listed Sponsors
collaborator

OpenBiome

INDUSTRY

lead

Milton S. Hershey Medical Center

OTHER